In situ 1 H NMR monitoring of metyrapone incubations with resting-cells of two strains of Mycobacterium, Mycobacterium aurum MO1 and Mycobacterium sp. RP1, showed the biotransformation of this compound, and more precisely the carbonyl-reduction of metyrapone into the corresponding alcohol, metyrapol. This reduction produced both enantiomers. The use of inhibitors allowed us to show the multiple enzymatic activities involved in this biotransformation including carbonyl reductase (EC 1.1.1.184) from the short-chain dehydrogenase superfamily and aldehyde reductase (EC 1.1.1.2) from the aldo-keto reductase superfamily.
Evidence of metyrapone reduction by two Mycobacterium strains shown by 1 H NMR Introduction
Carbonyl reductases belong to the oxido-reductase enzymes and are able to transform a wide range of aliphatic and aromatic xenobiotic carbonyl compounds, in particular into the corresponding alcohols. These reduction reactions are carried out in main by members of two distinct superfamilies, the short-chain dehydrogenase/reductase superfamily (SDR) and the aldo-keto reductase superfamily (AKR). SDR members are soluble proteins, mostly dimers or tetramers, containing about 270 amino acids for the monomer and a characteristic catalytic triad (Ser, Tyr and Lys) in the active site (Jornvall et al. 1999; Kallberg et al. 2002; Oppermann et al. 2003) . The AKR members are usually monomeric, NAD(P)H dependent, about 320 amino acids in length with an active site containing a conserved tetrad (Tyr, His, Asp and Lys) (Jez et al. 2001; Hyndman et al. 2003) . Both AKR and SDR seem to be the result of a convergent evolution in that many enzymes of these superfamilies exhibit pluripotency for steroidal and non-steroidal carbonyl substrates (Maser 1995) . Carbonyl reducing enzymes can accept many structurally different substrates (endogenous as well as xenobiotics: pharmaceuticals agents or toxicologically important derivatives), but they can be distinguished by the substrates they use and their specific inhibitors (Forrest & Gonzalez 2000; Oppermann & Maser 2000) . The presence of carbonyl reductases has been reported in various organisms, but the majority of the research work was performed in mammalian cells and tissues, their essential role being the protection from damage by the accumulation of toxic carbonyl compounds. They can thus participate in detoxication processes (Maser & Oppermann 1997; Finckh et al. 2001) .
Considering microorganisms, carbonyl reduction was mainly investigated by chemists, the aim of their studies being the production of optically active alcohols (Besse et al. 1997; Roberts 1997; Faber 1998) . If the enantiomeric excess obtained for the alcohol is not good enough, authors concluded that either the enzyme involved is not enantiogenic, or the reduction is the result of multiple enzymatic activities. Therefore, the class of the enzyme involved in such reaction was often unclear. Only a few papers report serious work on the purification, identification and characterization of carbonyl reductases and aldehyde reductases from microorganisms: Saccharomyces cerevisiae (Ford & Ellis 2001 , 2002 , Sporobolomyces salmonicolor and Candida magnoliae (Kita et al. 1999) , Geotrichum candidum (Matsuda et al. 2000) , Rhodococcus erythropolis (Zelinski et al. 1994) , Escherichia coli (Habrych et al. 2002) . However, reduction of carbonyl xenobiotics by microorganisms can have a great importance for biotechnological uses (Ellis 2002) or in the environmental field.
Recently, we have studied the biodegradative pathway of morpholine and analogues (heterocyclic compounds) by two Mycobacterium strains in more detail using in situ 1 H NMR Combourieu et al. 1998 Combourieu et al. , 2000 Poupin et al. 1998; Delort & Combourieu 2001) . This technique, both qualitative and quantitative, allows the study of molecules at natural abundance directly in the incubation medium without any previous step of purification. We have shown that the first step of biodegradation proceeded via an oxidation in α-position of the heteroatom (nitrogen) by a cytochrome P450 catalyzed reaction. The involvement of such an enzyme was evidenced by the use of metyrapone, a selective cytochrome P450 inhibitor. In situ monitoring of this inhibitory reaction by 1 H NMR revealed that metyrapone 1, an aromatic ketone, was reduced to metyrapol 2 ( Figure 1 ). As this type of reduction is commonly used to test carbonyl reductase activity (Maser & Netter 1989 , 1991 , this observation prompted us to investigate further the presence of such an enzyme in these Mycobacterium strains.
Materials and methods

Chemicals
Metyrapone, p-nitrobenzaldehyde (p-NBA) and tris-[3-(trifluoromethyl-hydroxymethylene)-d-camphorato] europium III (Eu(tfc) 3 ) were purchased from Aldrich Chemical (St Quentin Fallavier, France) and tetradeuterated sodium trimethylsilylpropionate (TSPd 4 ) was purchased from EurisoTop (St Aubin, France).
Growth conditions
Mycobacterium aurum MO1 and Mycobacterium sp. RP1 cultures were grown in 100 mL of Trypcase soy broth (bioMérieux, Marcy l'Etoile, France) in 500-mL Erlenmeyer flasks incubated at 30 • C with agitation at 200 rpm. They were harvested after 48 h of culture.
Incubation with xenobiotics
Cells were harvested by centrifugation at 9,000 × g for 15 min at 5 • C. The supernatant was eliminated and the pellet was washed twice with phosphate buffer (containing per liter of distilled water, KH 2 PO 4 1 g, K 2 HPO 4 1 g, FeCl 3 4 mg and MgSO 4 .7H 2 O 40 mg, pH 6.6) and finally resuspended in this buffer (5g of wet cells in 50 mL of buffer). The cells were incubated with 5 mM of metyrapone or p-nitrobenzaldehyde in 500 mL Erlenmeyer flask at 30 • C with agitation (200 rpm). Incubation of cells under the same conditions in the absence of the substrate constituted a negative control, as did incubation of the substrate in the buffer without cells. Samples (1 mL) were taken regularly. They were centrifuged at 12,000 × g for 5 min. The supernatants were isolated and immediately frozen until NMR analysis. (ii) 1 H NMR spectra. 1 H NMR was performed at 300.13 MHz on a Bruker Avance 300 spectrometer at 21 • C with 5 mm-diameter tubes containing 600 µL of sample. About 150 scans were collected (90 • pulse, 7 µs; relaxation delay, 5 s; acquisition time, 4.561 s; 32000 data points). No filter was applied before Fourier transformation but a baseline correction was performed on spectra before integration with Bruker software. Under these conditions, the limit of quantification was in the range of 0.05 mM. 
Synthesis of racemic metyrapol
To a solution of 1 g (4.4 mmol) of metyrapone in 40 mL of absolute ethanol was added 62.8 mg (1.7 mmol) of NaBH 4 . The mixture was stirred overnight at room temperature. Ethanol was then evaporated under vacuum and the residue was diluted with 25 mL of a mixture water/HCl 0.1N 4/1 v/v. This aqueous phase was extracted three times with chloroform and the organic layer was dried on MgSO 4 . After evaporation of the solvent, racemic metyrapol was obtained quantitatively. RMN 1 H (400.13 MHz, CDCl 3 ) δ ppm: 1.28 (s, 3H, CH 3 ); 1.32 (s, 3H, CH 3 ); 4.58 (s, 1H, CHOH); 6.07 (s, 1H, OH); 7.05 (ddd, 1H, H-5, J = 0.8 Hz, J = 4.8 Hz, J = 7.9 Hz); 7.12 (ddd, 1H, H-5 , J = 0.8 Hz, J = 4.8 Hz, J = 8.0 Hz); 7.23 (ddd, 1H, H-4, J = 1.6 Hz, J = 2.3 Hz, J = 7.9 Hz); 7.53 (ddd, 1H, H-4 , J = 1.5 Hz, J = 2.5 Hz, J = 8.0 Hz); 8.11 (dd, 1H, H-2, J = 0.8 Hz, J = 1.7 Hz); 8.24 (dd, 2H, H-6, J = 1.6 Hz, J = 4.8 Hz); 8.38 (dd, 1H, H-2 , J = 0.8 Hz, J = 2.1 Hz). RMN 13 C (100.62 MHz, CDCl 3 ) δ ppm: 23.4 (CH 3 ); 24.6 (CH 3 ); 41.8 (C(CH 3 ) 2 ); 78.4 (CHOH); 122.3 (C-5); 122.5 (C-5 ); 135.1 (C-4 ); 135.3 (C-4); 137.5 (C-3); 141.2 (C-3 ); 146.5 (C-6 ); 147.7 (C-6); 148.2 (C-2 ); 148.5 (C-2).
Synthesis of the (−)-metyrapol
The optically pure (−) enantiomer of metyrapol was obtained by chemical resolution with (−)-O,O-dip-toluoyltartaric acid according to Howe & Moore (1971) . mp = 107-108 • C. (Nagamine et al. 1997) . Spectral data were identical to those of the racemic mixture.
Enzymatic assays
Enzyme activities were assessed by HPLC as described previously (Maser & Bannenberg 1994; Oppermann & Maser 1996) : Final concentrations: NADH 3.2 mM; NADPH 3.2 mM, NADPH-regenerating system: NADP + 0.8mM; glucose-6-phosphate 6mM, glucose-6-phosphate dehydrogenase 0.35U, MgCl 2 3 mM; carbonyl substrate: 1 or 5mM. Reversed phase HPLC conditions: Octadecyl-Si 100 polyol 4.5 mm × 25 cm (Serva, Heidelberg, Germany); eluent: 30% acetonitrile (v/v) in 30mM phosphate buffer pH 7.4; λ = 254 nm.
Western blot analysis
Electroblotting was performed in a semi-dry blotting system. Proteins were transferred to a nitrocellulose membrane and antigen-antibody complexes were visualized by chemiluminescence (ECL PLUS TMdetection system, Amersham Pharmacia Biotech). Primary antisera were diluted 1/40,000, the secondary antibody (peroxidase conjugated swine anti-rabbit immunoglobulin, DAKO) was used in a 1/5,000 dilution. Under these conditions, the detection limit of our antibody preparation was determined at around 5 ng of 3α-HSD/CR protein.
Results and discussion
Metyrapone reduction by Mycobacterium strains
Kinetics of metyrapone transformation were followed by in situ 1 H NMR spectroscopy, performed directly on the incubation medium after centrifugation. By studying the spectra obtained at different times of incubation, we could observe the decrease of the signals corresponding to metyrapone and the appearance of new signals. In the aromatic region, most of the signals overlap, giving difficulties for their identification. The evolution of the different compounds is more visible on the expanded region between 1.2 and 2.3 ppm of the spectra obtained at different incubation times ( Figure  2) .
The singlet at 1.7 ppm, corresponding to the methyl groups of metyrapone, is decreasing whereas new signals appeared, in particular a very intense singlet at 1.4 ppm, which corresponds to the major metabolite. The very similar shape and chemical shifts of the signals of this metabolite with those of metyrapone seems to evidence a close chemical structure. In order to eliminate the signals of by-products and to identify unambiguously the structure of the major metabolite, the supernatant, obtained after centrifugation of a 30 h incubation medium of metyrapone with M. aurum MO1, was extracted with chloroform and analysed by 1 H and 13 C NMR spectroscopy. The comparison of the spectra obtained with those reported in the literature (Pospisil et al. 1994 ) allowed us to identify the major metabolite as metyrapol, the compound being the result from reduction of the carbonyl function in metyrapone. This structure was also confirmed by mass spectrometry (Chemical Ionization):
Quantitative analysis of the kinetics of biotransformation of metyrapone was performed by integrating the singlet of metyrapone and metyrapol at 1.7 and 1.4 ppm respectively, directly on the 1 H NMR spectra : the measured areas were compared to the integral of TSPd 4 signal (reference) in order to calculate the different concentrations of metabolite and the parent molecule (Figure 3 ). The transformation of metyrapone (5mM) into metyrapol was not complete and reached a plateau after 20 h of incubation, corresponding to a 50% disappearance of metyrapone (formation of 2.2 mM of metyrapol). The formation of other metabolites was also observed as unidentified signals were present on the 1 H NMR spectra. In the literature, some authors (Damani et al. 1979 (Damani et al. , 1981 De Graeve et al. 1979 ) report the formation of several N-oxide derivatives during the metabolism of metyrapone by rats due to a pyridine N-oxidase. However, in our case, the sum of the substrate and product concentration decreases only very slightly during the incubation period, showing that other pathways of metyrapone metabolism do not seem to be important with Mycobacterium aurum MO1.
The ability of another strain of the same genus, Mycobacterium sp. RP1, to reduce metyrapone (5 mM) was also tested. Metyrapol was the major metabolite observed, but the kinetics of the biotransformation were much slower with this strain: 35 h of incubation are needed to reduce 50% of metyrapone.
Enantioselectivity of metyrapone reduction
Reduction of ketones by microorganisms is known to be achieved with varying degrees of enantioselectivity. The stereochemical mechanism of metyrapone reduc- tion has already been studied in a few cases: In vivo metabolism of metyrapone by humans (Chiarotto & Wainer 1995) , rats (Nagamine et al. 1997) or filamentous fungus (Howe & Moore 1971) or in vitro biotransformation by rat liver extracts (Nagamine et al. 1997) yielded the corresponding alcohol with poor to excellent enantiomeric excess. In order to study the stereoselectivity of the reductive metabolism of metyrapone by Mycobacterium strains, racemic and optically active metyrapol were synthesized as references. Racemic metyrapol was obtained by a borohydride reduction of metyrapone in a quantitative yield. The optically pure (−) enantiomer of metyrapol was obtained by chemical resolution with (−)-O,Odi-p-toluoyltartaric acid according to Howe & Moore (1971) .
The enantiomeric excess of metyrapol formed during the incubation of metyrapone with the Mycobacterium strains was determined by 1 H NMR after adding a chemical shift reagent, an europium derivative: tris-[3-(trifluoromethyl-hydroxymethylene)-d-camphorato] europium (III) (Günther 1994) . With an equal weight of metyrapol and of the europium derivative ( Figure 4A) , two proton signals of one pyridine ring were duplicated, each peak corresponding to one enantiomer. To assign the signals to each enantiomer, the same experiment was carried out with the synthesized optically pure (−)-enantiomer ( Figure  4B ). Figure 4C represents the expanded spectrum obtained after the addition of the europium derivative to a chloroformic extract of a supernatant, corresponding to a 96 h incubation of Mycobacterium aurum MO1 with 5 mM of metyrapone.
The ratio (+)/(−)-metyrapol, determined by the integration of the corresponding peak around 8 ppm, was about 50/50 whatever the used Mycobacterium strain was. Reduction of metyrapone by Mycobacterium sp. RP1 or by M. aurum MO1 yielded racemic metyrapol. No enantioselectivity was observed with these strains, indicating the involvement either of a sole enzyme with a non-enantiogenicity activity, or of several carbonyl reducing enzymes.
Enzyme(s) involved in the reduction of metyrapone
Several carbonyl metabolizing enzymes are able to reduce the carbonyl moiety of a compound to the corresponding hydroxy derivative. To get an idea of the type of enzyme involved in the case of metyrapone reduction in Mycobacterium strains, selective inhibitors were added to the incubation medium. This method is well-known to distinguish some AKRs from carbonyl reducing enzymes of the SDR type. Quercitrin, a flavonoid inhibitor of the SDR carbonyl reductase (EC 1.1.1.184) and phenobarbital, an inhibitor of the AKR aldehyde reductase (EC 1.1.1.2) were chosen (Oppermann & Maser 2000) .
The first studies on metyrapone reduction (5mM) were carried out with resting cells of Mycobacterium aurum MO1 in the presence of quercitrin (5 mM) or phenobarbital (5 mM). Both inhibitors had an effect on the rate of metyrapone biotransformation. Half of metyrapone was transformed after 25 h of incubation in the presence of quercitrin instead of 9 h in its absence. Accordingly, the transformation rate of metyrapone was reduced by more than a factor of 2 in the presence of 5 mM of quercitrin, indicating the potential involvement of carbonyl reductase (SDR) in this reaction. A similar effect was also observed in the presence of phenobarbital (reduction of the transformation rate by a factor of 2), indicating the participation of aldehyde reductase in metyrapone reduction. No significant difference was observed between both inhibitors, except that the equilibrium between metyrapone and metyrapol was reached after 24 h upon inhibition by quercitrin and after 28 h upon inhibition by phenobarbital. This may indicate a slightly higher activity of aldehyde reductase rather than carbonyl reductase in metyrapone reduction in Mycobacterium aurum MO1. With in situ 1 H NMR analysis, we could observe that neither quercitrin, nor phenobarbital was transformed by Mycobacterium strains. Their concentrations remained stable during the incubation (data not shown)
These results clearly showed the presence of enzymes acting as carbonyl reductases in Mycobacterium strains. However, they do not allow us to precisely define the extent of contribution of the reductase (carbonyl reductase or aldehyde reductase) involved in metyrapone reduction. One of the problems is that working in vivo with whole-cell microorganisms, the effect of an inhibitor could be influenced by its limited access to the intracellular enzyme machinery. In addition, the potency of a selective inhibitor may be affected by the presence of other enzymes. However, even with cell extracts, the differentiation between these two carbonyl reducing enzymes is not always easy, as shown by Maser et al. (1991a, b) in the case of human and rat liver microsomes. Some preliminary assays were carried out with cell-extracts. Immunoblot results did not reveal the presence of a SDR-like 3α-hydroxysteroid dehydrogenase which has previously been shown to catalyze the carbonyl reduction of metyrapone in Comamonas testosteroni (Oppermann & Maser 1996) . Hence, other SDRs or AKRs seem to be involved. Cell extracts of Mycobacterium aurum MO1 and Mycobacterium sp. RP1 were incubated with metyrapone, showing low activities with this substrate (for example: Km = 10.72 mM; Vmax = 0.609 nmol/mg of protein per min in the case of Mycobacterium sp. RP1). Metyrapol formation occurred with either NADPH or NADH as cofactor, although the activity with NADPH was weaker. Another well-studied substrate of carbonyl reducing enzymes, p-nitrobenzaldehyde (p-NBA) was also tested with cell extracts. p-NBA has been shown to be a substrate of other metyrapone reducing enzymes (Maser & Bannenberg 1994) . However, since the sterical demand of metyrapone is higher than that of p-NBA, the latter might be substrate of other carbonyl reductases as well. p-NBA was a better substrate for the Mycobacterium strains giving higher affinities (Table 1) . Even if both electron donors were accepted, a strong preference for NADPH was observed with p-NBA. Assays in the presence of quercitrin as inhibitor showed a different behaviour of both strains with a Ki value seven times higher in the case of Mycobacterium RP1. This result again demonstrates the multiplicity of bacterial reductases in the Mycobacterium strains.
Conclusions
Metyrapone, the diagnostic cytochrome P450 inhibitor, is reduced at its ketone function to the correspond-ing alcohol metabolite, metyrapol, by two strains of Mycobacterium, Mycobacterium aurum MO1 and Mycobacterium sp. RP1. This biotransformation, clearly evidenced by in situ 1 H NMR performed directly on the incubation medium, is mediated by at least two enzymes, carbonyl reductase (EC 1.1.1.184) and aldehyde reductase (EC 1.1.1.2), as shown by the use of specific inhibitors. The multiplicity of reductases in these bacteria, which is further substantiated by the use of p-NBA as a substrate and the resulting difference in sensitivity towards quercitrin, could also explain why the reduction took place without any enantiospecificity. A way to determine more precisely which reductases are involved in metyrapol formation, it would be interesting in the future to purify the enzymes from these strains, or to screen the known genome sequence of another Mycobacterium strain, Mycobacterium tuberculosis (Cole et al. 1998 ) for homologies with known reductases (Kallberg et al. 2002) . In fact, these enzymes -and the microorganisms having these enzymes -may have a great importance in the environmental field, and particularly in detoxification processes: the compounds formed are more hydrophilic, can be easily excreted and are generally less toxic than the parent carbonyl compound.
